PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Angels on the Park is a nursery opening in East London that provide flexible childcare, extended their operating hours and arrange babysitting in the family home.
(EIS pending) (SEIS Pending)
days to go:
Expired
investment:
£61,450
Active Food Systems, trading as Synergy Grill, has developed and patented innovative and commercial cooking technology for the food and hospitality industry. Its ‘Fat Atomising Grill' makes cleaning quick and easy while delivering cost savings through a 59% reduction in fuel consumption. The company has sold 2000+ units of the grill to entities like Whitbread, Greene King, Marriott, Radisson and Marstons among others. Synergy Grill asserts that its performance in the first half of the year has been profitable despite COVID-19. They have contracts with reputed organisations like Whitbread and Marstons have generated revenues of £970,000. The company is in conversation with over 50 pubs and restaurants including product trials with Nandos, Weatherspoons and Mitchell Butler that are interested in its product. It will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£316,488
Miso Tasty make Japanese inspired snacks and meals and currently have a range of Miso soups, Miso pastes, meal kits and even a cookbook. Their products are stocked in over 1,000 stores nationwide such as Waitrose, Sainsburys, Ocado, Wholefoods and Selfridges.
days to go:
Expired
investment:
£421,400
The Five Points Brewing Company (TFPBC) is one of London's best-known craft breweries that brews modern, flavourful, craft beer, The company asserts that its beers are stocked nationwide in pubs and across major chains like Waitrose, Tesco and Nando's. TFPBC claims that it has grown from £173,000 worth of sales in 2013 to £4.8 million in 2019. The company's first pub, The Pembury Tavern, has been graced with awards and recommendations from multiple entities. TFPBC argues that it has developed its e-commerce site in the wake of COVID-19 achieving online sales of over £300,000 from selling three million pints in draught, bottle and can form since March 2020. It also won the Champion Beer Of London 2019 Award. The company will use the investment to open its new on-site taproom with a large outdoor area for beer sales direct to the public, build a new flagship brewery site in Hackney, drive new sources of revenue whilst reducing costs, and maintain its commitment to East London
days to go:
Expired
investment:
£841,392
Launched in October 2016, Big Drop Brewing is a world-leading alcohol-free craft brewer. The company brews beer naturally by using specialist brewing methods to ensure the alcohol never exceeds 0.5%. The beer is not only Alcohol-Free, but is also gluten-free and many are low in sugar. Their award-winning lager is vegan-friendly. The company does not have a brewery of its own but partners with reputable breweries around the world, who share their brewing values to produce the beer. Big Drop Brewing has secured private funding already and meaningful distribution in the UK and 12 overseas markets. They have also secured off-trade listings in Tesco, Morrisons and Ocado. Half of the investment will be used for Sales & Marketing, 30% for new branding launch and related marketing, 10% for production costs and the remaining 10% for product development.
days to go:
Expired
investment:
£617,566
The mission at sano is to bring education and knowledge to everybody, so that they can eat healthly and take control of their own health. The strategy behind Sano to go is to become a leader in the healthy food delivery market.
days to go:
Expired
investment:
Withheld
